First Manhattan CO. LLC. raised its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 15.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 784,551 shares of the semiconductor company’s stock after purchasing an additional 103,560 shares during the period. Synopsys accounts for about 1.0% of First Manhattan CO. LLC.’s holdings, making the stock its 22nd biggest position. First Manhattan CO. LLC. owned 0.41% of Synopsys worth $368,519,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the business. Sowell Financial Services LLC increased its stake in shares of Synopsys by 2.0% in the fourth quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after purchasing an additional 21 shares in the last quarter. Natural Investments LLC increased its stake in shares of Synopsys by 4.6% in the fourth quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after purchasing an additional 21 shares in the last quarter. Financial Management Professionals Inc. increased its stake in shares of Synopsys by 7.0% in the fourth quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after purchasing an additional 22 shares in the last quarter. Foronjy Financial LLC increased its stake in shares of Synopsys by 5.2% in the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock worth $210,000 after purchasing an additional 22 shares in the last quarter. Finally, Barden Capital Management Inc. increased its stake in shares of Synopsys by 1.2% in the fourth quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock worth $877,000 after purchasing an additional 23 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Insider Activity at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on SNPS
Synopsys Price Performance
SNPS stock opened at $461.74 on Thursday. The firm has a 50 day moving average of $477.08 and a 200-day moving average of $461.83. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The firm has a market capitalization of $88.41 billion, a P/E ratio of 106.88, a price-to-earnings-growth ratio of 2.63 and a beta of 1.22.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period in the previous year, the business posted $3.67 earnings per share. Synopsys’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys announced the first wave of its Multiphysics Fusion solutions, which integrate multiphysics analysis into design workflows and could improve chip design speed, accuracy, and customer adoption. Synopsys Announces Availability of the First Wave of Multiphysics Fusion Solutions
- Positive Sentiment: Synopsys also expanded its ecosystem through a partnership with Murata to provide simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, a move that supports its engineering software platform. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
- Neutral Sentiment: A 247WallSt. commentary said SNPS has been stuck in a weak trading pattern this year, but still projected a year-end price target above current levels, reinforcing a mixed but not bearish long-term view. Synopsys Stock Will End The Year at This Price
- Neutral Sentiment: A DCF-based valuation piece said Synopsys looks fairly valued around $394, suggesting the stock may not be deeply undervalued despite recent weakness. SNPS Fairly Valued by DCF at 394
- Negative Sentiment: CEO Sassine Ghazi sold 14,603 shares and CFO Shelagh Glaser sold 3,394 shares under pre-arranged 10b5-1 plans, which may be routine but can still weigh on investor sentiment. Top Synopsys Executive Makes Major Move With Insider Stock Sale
- Negative Sentiment: Brokerage coverage continues to show a cautious stance overall, with consensus at “Hold,” which may limit enthusiasm despite solid earnings and revenue growth. Synopsys, Inc. Given Consensus Rating of Hold by Brokerages
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
